MENU
INDP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Indaptus Therapeutics (INDP) Ownership - Who owns Indaptus Therapeutics?
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy... Show more
Profile
Industry
N/A
Address
3 Columbus Circle
Phone
+1 646 427-2727
Employees
7
Web
https://www.indaptusrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.79M
P/E Ratio
N/A
Total Cash
7.38M
Projected Growth
N/A
Total Debt
107.99K
Revenue
N/A
Risk (Beta)
1.03
Dividend Yield
N/A
Total Cash/Share
0.51
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
INDP
Capitalization
7.79M
P/E Ratio
N/A
Risk (Beta)
1.03
Dividend Yield
N/A
Total Cash
7.38M
Total Cash/Share
0.51
Total Debt
108K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
6M
P/B Ratio
1.88
Cash Flow
N/A
Earnings
-1.7
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
102K
Current Ratio
3.42
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-15.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-114.42
Shares Held By Institutions
926K
Shares Outstanding - Current
14.4M
Total Liabilities
2.24M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-34.699
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3 Columbus Circle
Phone
+1 646 427-2727
Employees
7
Web
https://www.indaptusrx.com